Sermorelin Workplace Considerations: What to Expect on the Job

HealthRX.com

No approved sermorelin schedule exists for workdays

Print or save as PDF

Key numbers

  • 3 hoursHow long growth hormone stayed raised after an IV dose in healthy men; no work performance was measuredSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 30 micrograms per kgOnce-daily bedtime dose given to children in the year-long pediatric studySource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 0.5 mgLower dose given twice daily to 10 older men in the adult studySource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 14 daysLength of twice-daily treatment in the older-men study (0.5 or 1 mg doses)Source: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • Approval status / No FDA-approved sermorelin product; Geref's approvals were withdrawn in 2009 [1]
  • Drug class / GHRH analogue, 29 amino acids; not growth hormone [6]
  • Study doses / 30 micrograms/kg nightly in children; 0.5 or 1 mg twice daily for 14 days in older men [2][3]
  • Hormone effect / Growth hormone stayed raised about 3 hours after an intravenous dose [4]
  • Sport / Prohibited at all times under WADA S2.2.4 [5]
  • Safety follow-up / One year in the pediatric study, with no adverse biochemical or hormonal changes [2]

Is there an approved schedule to build a workday around?

No. Sermorelin was FDA-approved as Geref for two uses only: a diagnostic test of the pituitary's ability to release growth hormone, and treatment of idiopathic growth hormone deficiency in children with growth failure [1]. The manufacturer discontinued it in 2008 and FDA withdrew both approvals effective June 18, 2009 [1]. In 2013 FDA determined Geref was not withdrawn from sale for reasons of safety or effectiveness [1]. It was never approved for adults, anti-aging, weight loss or athletic performance [1].

Sermorelin sold in the US today is compounded, and compounded drugs are not FDA-approved: FDA does not review their safety, effectiveness or quality before they are marketed [7].

What the studied injection schedules actually look like

In the year-long pediatric study of 110 previously untreated children, 30 micrograms per kg was given once daily subcutaneously at bedtime [2]. In the adult study, 10 healthy older men with a mean age of 68 received 0.5 mg or 1 mg subcutaneously twice daily for 14 days [3]. Neither study schedule is a current FDA-approved dose, because no sermorelin product is FDA-approved today [1].

Will it affect you during work hours?

We found no study that tested sermorelin against alertness, reaction time, decision-making, driving or any job task. In a study of 30 healthy men aged 19 to 43, GHRH(1-29) was rapidly eliminated after an intravenous injection, yet growth hormone levels stayed elevated for about 3 hours [4]. That study measured hormone levels, not how anyone felt or performed.

What people on Reddit report

Accounts from people using sermorelin mainly to improve sleep, often alongside tirzepatide and with weight-loss or body-composition goals. None of them describe work performance directly.

verymuchfull · BodyHackGuide

One month in and have only seen improvement in my sleep. But MAJOR. Helps me go into deep sleep for hours which I struggled with before.

Reports one month in, with much better deep sleep than before.

Read the source discussion

ConsequencePublic447 · BodyHackGuide

6 mths tirz and 1 mth Sermorelin,, it has improved my sleep as far but was told not to expect any drastic body composition changes from it, minimal change after 2-3 months.

Reports better sleep on sermorelin with little body-composition change, and was told not to expect large changes.

Read the source discussion

Questions worth asking

Choose the questions you want to keep

Sport rules

WADA's 2026 Prohibited List names sermorelin in S2.2.4, growth hormone releasing factors, and prohibits it at all times, in and out of competition [5]; the 2027 List, in force January 1, 2027, names it again [8].

What the safety follow-up shows

In the one-year pediatric study, no adverse changes appeared in general biochemistry or hormone tests, fasting glucose did not change, IGF-I was not excessively raised, and sermorelin was well tolerated [2]. Those findings are from children; the older-men study covered 14 days of treatment in 10 men [3].

Check what you know

Think you have it? Try 3 quick questions and see what the article says.

1. According to the article, which of these was one of Geref's two FDA-approved uses?

Question 1 of 3

Score: 0 right, 0 of 3 answered

Can I take sermorelin in the morning before work?
There is no approved schedule. The pediatric study gave 30 micrograms per kg once daily at bedtime [2], and the adult study used 0.5 mg or 1 mg twice daily for 14 days [3]. Neither compared morning with bedtime dosing.
Is sermorelin banned in sport?
Yes. WADA names sermorelin in S2.2.4 as a growth hormone releasing factor, prohibited at all times, in and out of competition [5], and names it again in the 2027 List [8].
Is sermorelin FDA-approved?
No. Geref was approved for a pituitary diagnostic test and for growth hormone deficiency in children, was discontinued in 2008, and its approvals were withdrawn effective June 18, 2009 [1].
How long does a sermorelin dose last?
After an intravenous dose in healthy men the peptide was rapidly eliminated, but growth hormone levels stayed elevated about 3 hours [4]. The treatment studies used subcutaneous injections [2][3].
Show all 11 referencesHide references
  1. Federal Register :: Request Access.
  2. Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, et al. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. J Clin Endocrinol Metab. 1996;81(3):1189-96.
  3. Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992;75(2):530-5.
  4. Wilton P, Chardet Y, Danielson K, Widlund L, Gunnarsson R. Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration. Acta Paediatr Suppl. 1993;388:10-5.
  5. World Anti-Doping Agency.
  6. Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
  7. Official web page.
  8. World Anti-Doping Agency.
  9. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
  10. U.S. Food and Drug Administration.
  11. Reddit participants. Sermorelin (r/BodyHackGuide). Accessed 2026-11-11.
Sermorelin workplace: evidence summary chart
Image: HealthRX.com. Full sermorelin workplace guide and sources at healthrx.com/lifestyle-sermorelin.